Medicinal Product Shortages - update - 16 October 2019

Notice type: Advisory

Date: 16/10/2019


Further Information:

The Health Products Regulatory Authority has been notified of a shortage of the following products:

  • Champix 1mg Film Coated Tablet – EU/1/06/360/016
  • Cykloapron 500mg/5ml Solution for Injection/Infusion – PA0822/117/001
  • Femoston-Conti 0.5mg/2.5mg Tablet – PA2010/012/003
  • Losartan Hydrochlorothiazide 100mg/25mg Tablet – PA0749/026/002
  • Mitomycin Kyowa 10mg Powder for Solution for Injection – PA2288/002/001
  • Mitomycin Kyowa 40mg Powder for Solution for Injection – PA2288/002/002
  • Septrin Forte 160mg/800mg Tablet – PA1691/010/002
  • Tamoxifen 20mg Tablet – PA0577/207/001
  • Tractocile 6.75mg/0.9ml Solution for Injection – EU/1/99/124/001
  • Warfant 3mg Tablet – PA0073/139/002


The following shortage has been resolved and supply has resumed to the Irish market:

  • Caverject 20mcg powder and solvent for solution for injection – PA822/115/003
  • Cozaar-Comp 50mg/12.5mg Tablet – PA1286/001/003
  • Cozaar-Comp 100mg/25mg Tablet – PA1286/001/002
  • Ondansetron 8mg Tablet – PA0749/009/002
  • Puri-Nethol 50mg Tablet – PA1691/009/001
  • Relpax 40mg Film Coated Tablet – PA0822/006/002
  • Telmisartan 80mg Film Coated Tablet – PA0126/228/003

Please see the shortages section of the HPRA website for further information.

The HPRA will be sending weekly updates concerning medicinal product shortages. However, the above webpage will be updated in real time.

« Back